Diagnosis and management of patients with Crohn's disease. Position paper from the GETAID.

The therapeutic arsenal for treating Crohn's disease has grown rapidly, expanding to include advanced therapies with various modes of action. Over the last two decades, physicians and patients have significantly improved the treatment of Crohn's disease, setting ambitious goals. In 2024, French clinical guidelines were established through a validated process involving the adaptation of international gastroenterology societies' clinical guidelines and French consensus meetings. The French guidelines aimed to ensure the applicability of new approaches in France, taking into account specific restrictions on drug authorization and reimbursement. This position statement outlines the specificity of the French guidelines compared to other international recommendations.

Published by Clinics and research in hepatology and gastroenterology, 2025. The guideline itself is at the source linked here.

doi.org/10.1016/j.clinre.2025.102728